Global Variation of Human Papillomavirus Genotypes and Selected Genes Involved in Cervical Malignancies

Annals of Global Health

Volumn 81, Issue 5, 2015, Pages 675-683

  Husain, R S Akram ^a   Ramakrishnan, V ^a  

^a CHETTINAD HOSPITAL AND RESEARCH INSTITUTE   (India)

Author keywords

cervical cancer; HPV vaccines; human papillomavirus; mutation; oncogene

Indexed keywords

CANCER VACCINE; KRAS PROTEIN, HUMAN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; PROTEIN P21; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; WART VIRUS VACCINE;

CDKN2A GENE; DATA BASE; EP300 GENE; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; GENE; GENETIC VARIABILITY; GENOTYPE; INDIA; KRAS GENE; NOL7 GENE; ONCOGENE; PAPILLOMAVIRUS INFECTION; PIK3CA GENE; PTEN GENE; REVIEW; STK11 GENE; TP53 GENE; UTERINE CERVIX CANCER; WART VIRUS; ADENOCARCINOMA; BRAZIL; CARCINOMA, SQUAMOUS CELL; ETHIOPIA; FAR EAST; FEMALE; GENETICS; GHANA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; MEXICO; MUTATION; NIGERIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SAUDI ARABIA; SOUTH AFRICA; SOUTH AND CENTRAL AMERICA; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADENOCARCINOMA; BRAZIL; CARCINOMA, SQUAMOUS CELL; ETHIOPIA; FAR EAST; FEMALE; GENOTYPE; GHANA; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; INDIA; LATIN AMERICA; MEXICO; MUTATION; NIGERIA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHOSPHATIDYLINOSITOL 3-KINASES; PREVALENCE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS P21(RAS); SAUDI ARABIA; SOUTH AFRICA; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84964068122     PISSN: None     EISSN: 22149996     Source Type: Journal    
DOI: 10.1016/j.aogh.2015.08.026     Document Type: Review

References (45)

1. D. Das, A.K. Rai, A.C. Kataki, and et al. Nested multiplex PCR based detection of human papillomavirus in cervical carcinoma patients of northeast India Asian Pac J Cancer Prev 14 2013 785 790
2. F. Cesira, C. Raffaella, and P. Marzia Role of Oxidative Stress in Human Papilloma Virus-driven Cervical Carcinogenesis 2014 Academic Press, San Diego, CA
3. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008; GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
4. J.G. Senapathy, P. Umadevi, and P.S. Kannika The present scenario of cervical cancer control and HPV epidemiology in India: an outline Asian Pac J Cancer Prev 12 2011 1107 1115
5. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC Cancer. Available at: http://globocan.iarc.fr. Accessed January 31, 2015.
6. IARC IARC Handbooks on the Cancer Prevention: Cervix Cancer Screening 2005 IARC Press Lyon, France
7. IARC IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol. 64: Human Papilloma Viruses 1995 IARC Lyon, France
8. C.M. Oliveira, J.H. Fregnani, J.P. Carvalho, A. Longatto-Filho, and J.E. Levi Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil BMC Cancer 13 2013 357
9. P.P. Chong, N. Asyikin, M. Rusinahayati, and et al. High prevalence of human papillomavirus DNA detected in cervical swabs from women in southern Selangor, Malaysia Asian Pac J Cancer Prev 11 2010 1645 1651
10. E.M. Venceslau, M.M. Bezerra, A.C.M. Lopes, and et al. HPV detection using primers MY09/MY11 and GP5+/GP6+ in patients with cytologic and/or colposcopic changes J Bras Patol Med Lab 50 2014 280 285
11. P.K. Chan, C. Zhang, J.S. Park, and et al. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations Int J Cancer 132 2013 2528 2536
12. A.A. Chen, D.A. Heideman, D. Boon, and et al. Human papillomavirus 45 genetic variation and cervical cancer risk worldwide J Virol 88 2014 4514 4521
13. G. Alsbeih, N. Al-Harbi, M. El-Sebaie, and I. Al-Badawi HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia Infect Agents Cancer 8 2013 15
14. L. Denny, I. Adewole, R. Anorlu, and et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa Int J Cancer 134 2014 1389 1398
15. S.R. Leyh-Bannurah, C. Prugger, M.N. de Koning, H. Goette, and R.J. Lelle Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia Infect Agent Cancer 9 2014 33
16. M. Guardado-Estrada, E. Juarez-Torres, E. Roman-Bassaure, and et al. The distribution of high-risk human papillomaviruses is different in young and old patients with cervical cancer PLoS One 9 2014 e109406
17. rd ed. 2010 WHO Geneva, Switzerland
18. U. Sarma, J. Mahanta, B.J. Borkakoty, K.L. Talukdar, R. Gogoi, and K. Yadav Demographic characteristic of HPV infection in women - a hospital based study from Guwahati, India Nat J Med Res 3 2013 1 4
19. V.M. Berlin Grace HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India Indian J Cancer 46 2009 203 207
20. S. Franceschi, R. Rajkumar, P.J. Snijders, and et al. Papillomavirus infection in rural women in southern India Br J Cancer 92 2005 601 606
21. C. Duttagupta, S. Sengupta, M. Roy, and et al. Are Muslim women less susceptible to oncogenic human papilloma virus infection? A study from the rural eastern India Int J Gynecol Cancer 14 2004 293 303
22. P.R. Kulkarni, H. Rani, M.G. Vimalambike, and S. Ravishankar Opportunistic screening for cervical cancer in a tertiary hospital in Karnataka, India Asian Pac J Cancer Prev 14 2013 5101 5105
23. N.D. D'souza, N.S. Murthy, and R.Y. Aras Projection of cancer incident cases for India till 2026 Asian Pac J Cancer Prev 4 2013 4379 4386
24. J. Ferlay, I. Soerjomataram, M. Ervik, and et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 2015 E359 E386
25. S.M. Agarwal, D. Raghav, H. Singh, and G.P. Raghava CCDB: a curated database of genes involved in cervix cancer Nucleic Acids Res 39 Database issue 2011 D945 D950
26. S.A. Forbes, N. Bindal, S. Bamford, C. Cole, C.Y. Kok, D. Beare, and et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer Nucleic Acids Res 39 Database issue 2011 D945 D950
27. R.P. Souza, F. Gimenes, A.L. de Abreu, and et al. Differences in the mutation of the p53 gene in exons 6 and 7 in cervical samples from HIV-and HPV-infected women Infect Agent Cancer 8 2013 38
28. M. Martinez-Rivera, and Z.H. Siddik Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53 Biochem Pharmacol 83 2012 1049 1062
29. S. Andersson, A.C. Hellström, Z.P. Ren, and E. Wilander The carcinogenic role of oncogenic HPV and p53 gene mutation in cervical adenocarcinomas Med Oncol 23 2006 113 119
30. A.I. Ojesina, L. Lichtenstein, S.S. Freeman, and et al. Landscape of genomic alterations in cervical carcinomas Nature 506 2014 371 375
31. A.A. Wright, B.E. Howitt, A.P. Myers, and et al. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix Cancer 119 2013 3776 3783
32. S.N. Wingo, T.D. Gallardo, E.A. Akbay, and et al. Somatic LKB1 mutations promote cervical cancer progression PLoS One 4 2009 e5137
33. S. Jancik, J. Drabek, D. Radzioch, and M. Hajduch Clinical relevance of KRAS in human cancers J Biomed Biotechnol 2010 2010 150960
34. F. Janku, J.J. Lee, A.M. Tsimberidou, and et al. PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers PLoS One 6 2011 e22769
35. K. Iida, K. Nakayama, M.T. Rahman, and et al. EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target Br J Cancer 105 2011 420 427
36. N.E. Hynes, and H.A. Lane ERBB receptors and cancer: the complexity of targeted inhibitors Nat Rev Cancer 5 2005 341 354
37. R. Hasina, A.L. Pontier, M.J. Fekete, and et al. NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype Oncogene 25 2006 588 598
38. C.L. Doci, T.P. Mankame, A. Langerman, and et al. Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer Int J Gynecol Pathol 31 2012 15 24
39. N. Murphy, M. Ring, C. Heffron, and et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer J Clin Pathol 58 2005 525 534
40. K. Oda, D. Stokoe, Y. Taketani, and F. McCormick High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma Cancer Res 65 2005 10669 10673
41. A.K. Adams, T.M. Wise-Draper, and S.I. Wells Human papillomavirus induced transformation in cervical and head and neck cancers Cancers 6 2014 1793 1820
42. R. Roden, and T.C. Wu How will HPV vaccines affect cervical cancer? Nature Rev Cancer 6 2006 753 763
43. M. Karimi Zarchi, N. Behtash, Z. Chiti, and S. Kargar Cervical cancer and HPV vaccines in developing countries Asian Pac J Cancer Prev 10 2009 969 974
44. S.S. Kulkarni, P.P. Vastrad, B.B. Kulkarni, and et al. Prevalence and distribution of high risk human papillomavirus (HPV) types 16 and 18 in carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India Asian Pac J Cancer Prev 12 2011 645 648
45. M. Paul Flicek, A. Ridwan, B. Daniel, and et al. Ensemble 2014 Nucleic Acids Res 42 Database issue 2014 D749 D755